Bringing Innovative Solutions to Healthcare Practitioners.


Bringing Innovative Solutions to Healthcare Practitioners.


Bringing Innovative Solutions to Healthcare Practitioners.

A Focus on Neurology

Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide. 

Our products are developed by Moleac with scientific excellence and evidence-based approach.

Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide. 

Challenging the Boundaries to The Possible.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

Patients taking NeuroAid yearly

Awards

Countries with Exclusive Partnership

Let’s talk about moleac with noemie & david picard

Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO. 

Latest News

Oct 02 2024
News

Join Us at the World Stroke Congress 2024 in Abu Dhabi – Visit Us at Booth 14!

We are thrilled to announce our participation at the World Stroke Congress (WSC) from October 23ʳᵈ to 26ᵗʰ, 2024, in Abu Dhabi.

Sep 25 2024
News

Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights from the EU-US CTAD Task Force Report

In their study, Angioni et al. report several general principles identified by the EU-US CTAD Task Force that should be considered when evaluating the meaningfulness of...
Sep 24 2024
News

Creating a Greener Workplace: Moleac’s Commitment to Sustainability

At Moleac, we are dedicated to sustainability, and we are excited to share the steps we are taking to create an eco-friendly workplace!

Sep 21 2024
News

Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives

Today is World Alzheimer’s Day!

Sep 11 2024
News

Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories

ANNOUNCEMENT – INDONESIA
We are pleased to share a joint statement from Moleac Pte. Ltd. and PT Prima Medika Laboratories (PML).

Sep 09 2024
News

World Alzheimer’s Day: Practical Tips to Support Patients and Caregivers

World Alzheimer’s Day is just around the corner! At Moleac, we’re committed to raising awareness about Alzheimer’s disease and fostering a deeper understanding of its...
Aug 30 2024
News

Shaping the Future of Alzheimer’s Care: Moleac at ASAD 2024 in Malaysia

Moleac was thrilled to participate in ASAD 2024 in Penang, Malaysia, alongside our esteemed partner, EP Plus Group..

Aug 27 2024
News

Upcoming S.H.A.P.E.S Webinar: Managing Post-Stroke Seizures

Pleased to support S.H.A.P.E.S with their upcoming webinar on Post-Stroke Seizure!

Aug 27 2024
News

Promoting Stroke Recovery: Highlights from the Stroke Society of the Philippines Annual Convention

Last week, we were delighted to attend the Stroke Society of the Philippines annual convention in Manila..

Aug 14 2024
News

Empowering Stroke Care: Moleac at the National Scientific Congress on Stroke in Vietnam

Together with EVD Pharma, our distributor in Vietnam, we were grateful to co-sponsor the National Scientific Congress on Stroke held in Ha Long early August..